QYNAPSE
Founded in 2015, QYNAPSE is a medical technology company, a spin-off from the CATI consortium of neuroimaging research laboratories in France. QYNAPSE develops and markets solutions maximizing the potential of quantitative imaging and artificial intelligence to optimize diagnosis, prognosis and monitoring of patients with neurological diseases. QYNAPSE is already marketing its QyScore® software for the automated quantification of imaging markers for clinical routine and clinical trials worldwide and is also launching QyPredict®, an AI prediction technology for better targeted patient selection in clinical trials. The company is headquartered in France, in the United States and in Canada.
QYNAPSE
Industry:
Artificial Intelligence Clinical Trials Health Care Information Technology Machine Learning Medical Neuroscience Software
Founded:
2015-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.qynapse.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
Mediktor
The most advanced and accurate sypmtom checker
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-01 | True Positive Medical Devices | True Positive Medical Devices acquired by Qynapse | N/A |
Investors List
AGORANOV
AGORANOV investment in Venture Round - Qynapse
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-21 | Qynapse Further Strengthens its Executive Leadership Team with the Appointment of Adam Schwarz, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.qynapse.com Semrush global rank: 8.07 M Semrush visits lastest month: 379
- Host name: ec2-13-37-53-75.eu-west-3.compute.amazonaws.com
- IP address: 13.37.53.75
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Qynapse"
Qynapse - Crunchbase Company Profile & Funding
Qynapse is on a mission to advance the accuracy and reliability of Central Nervous System (CNS) diseases screening and monitoring in both clinical routine settings and in clinical trial …See details»
Company - Qynapse - The future of neuroimaging is here
For healthcare providers, payers, pharma and, above all, patients and their loved ones, Qynapse brings groundbreaking peace of mind to the global fight against CNS disease. Founded in …See details»
Qynapse Company Profile 2024: Valuation, Funding
Qynapse General Information Description. Developer of a cloud-based quantitative imaging software designed to transform how patients are screened, therapy efficacy is assessed and health services are personalized. The …See details»
Qynapse - Contacts, Employees, Board Members, Advisors & Alumni
Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring. Search Crunchbase. Start Free Trial . Chrome …See details»
Qynapse - The Org
Qynapse offers peace of mind by combining MRI scans and AI to produce rapid, actionable insights into central nervous system (CNS) disordersSee details»
Qynapse - LinkedIn
Qynapse | 3,566 followers on LinkedIn. The future of neuroimaging is here. Qynapse offers groundbreaking peace of mind by providing results you can trust. | The future of neuroimaging …See details»
Qynapse Company Profile - Office Locations, Competitors ... - Craft
Qynapse Summary. Company Summary. Overview. Qynapse is a medical technology company. It unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis, and …See details»
Qynapse Unveils Strategic Rebrand To Support Accelerated …
Sep 20, 2021 We are excited to launch our new brand identity that better reflects the organization Qynapse has become, committed to bringing game-changing technology to serve …See details»
QYNAPSE Company Profile | PARIS 5, ILE DE FRANCE, France
Find company research, competitor information, contact details & financial data for QYNAPSE of PARIS 5, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
Qynapse Unveils Strategic Rebrand to Support …
BOSTON, MA, September 20, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, unveils a full rebrand …See details»
Qynapse - VentureRadar
" QYNAPSE develops and markets solutions that maximize the potential of neuroimaging and AI to revolutionize the clinical care continuum for Alzheimer’s disease, multiple sclerosis, …See details»
Qynapse - Funding, Financials, Valuation & Investors - Crunchbase
Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring. Search Crunchbase. ... How much funding has …See details»
Qynapse Unveils its New Brand and Latest Developments in
Nov 22, 2021 Qynapse is headquartered in France, in the US and in Canada. www.qynapse.com. Logo - https: ... Organization Profile. Qynapse. Contact Cision. 866-245 …See details»
Healthcare Provider - Qynapse - The future of neuroimaging is here
Powered by robust technology, QyScore® provides objective measures that have the potential to improve the accuracy of your diagnosis, evaluate therapeutic impact and more precisely …See details»
QYNAPSE (France) and TRUE POSITIVE MEDICAL DEVICES …
Oct 13, 2020 QYNAPSE SAS, a French medical technology company, today announces the acquisition of the Canadian company TRUE POSITIVE MEDICAL DEVICES Inc. (TPMD), a …See details»
QyScore Brain Imaging Software Earns FDA 510 (k) Clearance
Feb 5, 2020 The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QyScore, a cloud-based imaging software for the automated quantification of key magnetic …See details»
Why Qynapse - Qynapse - The future of neuroimaging is here
Qynapse offers groundbreaking peace of mind by providing results you can trust. To healthcare practitioners, we bring empowering, illuminating data. To pharma and biotech, we bring …See details»
News - Qynapse - The future of neuroimaging is here
Aug 6, 2020 QYNAPSE to sponsor and exhibit at the 106th RSNA Annual Meeting and present its latest AI-neuroimaging advancements, transforming care for patients with brain disorders …See details»
Qynapse Unveils its New Brand and Latest Developments in …
Nov 22, 2021 Qynapse Inc. is a medical technology company commercializing an AI-powered and proprietary neuroimaging software platform that creates the potential for earlier clinical …See details»